ROPHIBIO Competitors and Similar CompaniesClear all
ROPHIBIO's competitors and similar companies include Exicure, Zyngenia and Cure Genetics.
 Exicure Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets. |  Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways. |  Cure Genetics Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases. | ||
Founding Date | Founding Date 2007 | Founding Date 2011 | Founding Date 2009 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Cheongwon-gun, KR HQ Gaithersburg, US | Locations Skokie, US HQ Chicago, US | Locations Washington, US HQ | Locations HQ |
Employees | Employees N/A | Employees 29 | Employees N/A | Employees 15 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 25m (almost 16 years ago) | Latest funding round $ 9.5m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 94m | Total funding raised $ 25m | Total funding raised $ 26.5m |
For sources of this data, please see the company profile
View Company Profiles
Exicure
HQ
Skokie, US
Employees
29
Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
View companyZyngenia
HQ
Washington, US
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
View companyCure Genetics
HQ
Employees
15
Cure Genetics (also known as Suzhou Kerui Gene Biotechnology, 克睿基因) is a biotechnology company committed to developing applications of technologies in medicines and molecular diagnostics, which contribute to the treatment of cancers and genetic diseases.
View company